Authors:
Jan Cuypers, Kevin-Alexandre Jacquot
MIT Supply Chain Management Program
42
Summary:
The bi-directional global supply chain of high value Gene Therapy products currently lacks effective oversight capabilities to monitor the shipments performed by 3rd party couriers. Leverage advanced and innovative tools like Machine Learning and AI to develop a Control Tower to manage the key Risks of the fragmented supply chain and provide decision support capabilities. The new tools will improve monitoring capabilities and proactive thinking enhancing the supply chain’s Resilience.
Bravo